Calithera Biosciences (NASDAQ:CALA) Share Price Breaks Above Fifty Day Moving Average – Here’s Why

Calithera Biosciences, Inc. (NASDAQ:CALA – Get Free Report)’s stock price crossed above its fifty day moving average during trading on Monday. The stock has a fifty day moving average of $0.00 and traded as high as $0.0005. Calithera Biosciences shares last traded at $0.0005, with a volume of 345 shares trading hands.

Calithera Biosciences Trading Up 9,900.0%

About Calithera Biosciences

(Get Free Report)

Calithera Biosciences, Inc was a clinical-stage biopharmaceutical company focused on developing small-molecule therapies that target cancer metabolism. The company sought to exploit metabolic dependencies in tumor cells to create treatments for cancer, with research programs designed for use both as standalone therapies and in combination with existing medicines.

Calithera’s lead investigational product was telaglenastat (also known as CB-839), an oral inhibitor of glutaminase, an enzyme involved in glutamine metabolism.

Recommended Stories

Receive News & Ratings for Calithera Biosciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Calithera Biosciences and related companies with MarketBeat.com's FREE daily email newsletter.